Are Radiology Enterprises Prepared to Meet the Growing Demand for Alzheimer Disease Imaging?

In this discussion, Dr Tanenbaum, Tammie L.S. Benzinger, MD, PhD, a professor of radiology who serves as chief of MRI service at Mallinckrodt Institute of Radiology at Washington University School of Medicine in  St. Louis, Missouri, and Saurabh Sharma, MBA, a senior director for MR Strategy at Siemens Healthineers, explore whether imaging enterprises are prepared for the expected growth in the demand for brain MR imaging in patients with Alzheimer disease.

Creators and Guests

Host

Lawrence Tanenbaum, MD, FACR

Dr. Tanenbaum is a long term collaborator with the medical imaging industry, with interests in developing applications of contrast agents, MR, CT and advanced rendering in the clinical practice of medicine focusing on efficiency, radiation dose appropriateness and physiologic imaging. Dr. Tanenbaum has authored approximately 100 scholarly and peer reviewed articles, continues to chair educational and academic meetings and has delivered over 1500 invited lectures around the world.

SS

Guest

Saurabh Sharma

Guest

Tammie Benzinger, MD

Tammie L.S. Benzinger, MD, PhD, is a professor of radiology and serves as chief of MRI service at Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis. Benzinger’s research group, part of MIR’s Neuroimaging Labs Research Center, primarily focuses on the study of Alzheimer’s disease, mild cognitive impairment, autosomal dominant Alzheimer’s disease (ADAD) and related disorders.

What is Trends in Alzheimer Imaging & Management?

Moderated by Lawrence Tanenbaum, MD, FACR, Applied Radiology hosted a series of conversations with experts in Alzheimer disease imaging and management at the 2024 Radiological Society of North America Annual Meeting and Scientific Exhibition.